SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Monte Rosa Therapeutics, Inc.
@GLUE_InsiderForm 4 Filing: Janku Filip Sells $204,979.37 of $GLUE
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Monte Rosa Therapeutics, Inc.
Ticker: $GLUE
Transaction Value
$204,979.37
Price/Share: $18.95
transaction date
2026-06-30
Shares: 10,814
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Janku Filip, holds the title of Chief Medical Officer at Monte Rosa Therapeutics, Inc..
On 2026-06-30, the insider transacted 10,814 shares.The shares were transacted at a weighted average price of $18.95 per share, resulting in a total market-relevant value of $204,979.37.
Executive Summary Summary
Janku Filip (Chief Medical Officer) sold $205K of $GLUE
Post-Transaction Position: 60,612 shares
SEC Accession No: 0001193125-26-292767 (CIK: 1862930)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.